204 - Challenging Cases in Transplant Infectious Diseases

Interactive Moderator(s)

• 

  Steven Pergam, MD, MPH

  Professor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center Associate Professor, University of Washington School of Medicine
  Fred Hutchinson Cancer Center
  Seattle, WA, United States

  Disclosure(s): Global Life Technologies, Inc.: Grant/Research Support (Ongoing); Merck and Company, Inc.: Participated in research trial (Terminated)

  Slides
• 

  Maricar Malinis, MD

  Associate Professor of Medicine and Transplant (Surgery), Medical Director of Transplant and Oncology ID
  Yale School of Medicine
  New Haven, CT, United States

  Disclosure(s): Aicuris: Primary investigator of clinical trial at Yale site, renumeration goes to institution (Ongoing); Takeda: primary investigator of clinical trial at yale site, renumeration goes to institution (Ongoing)

Panelist(s)

• 

  Ricardo La Hoz, MD

  Associate Professor of Internal Medicine
  University of Texas Southwestern Medical Center
  Dallas, TX, United States

  Disclosure(s): No financial relationships to disclose
• 

  Erica Stohs, MD, MPH

  Assistant Professor
  Division of Infectious Diseases, Department of Internal Medicine
  University of Nebraska Medical Center
  Omaha, NE, United States

  Disclosure(s): BioFire Diagnostics: Grant/Research Support (Ongoing); Merck & Co. Inc: Grant/Research Support (Ongoing); ReViral: Grant/Research Support (Terminated)
• 

  Sanjeet Dadwal, MD, FACP, FIDSA

  Professor of Medicine & Chief, Division of Infectious Disease
  City of Hope National Medical Center
  Duarte, California, United States

  Disclosure(s): Allovir: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Amplyx Pharmaceuticals, Inc: Grant/Research Support (Ongoing); Ansun Biopharma: Grant/Research Support (Ongoing); AseptiScope Inc.: Advisor/Consultant (Ongoing), Stocks/Bonds (Ongoing); Astellas Pharma Inc.: Honoraria (Ongoing); Karius Inc.: Grant/Research Support (Ongoing); Merck & Co. Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing); Takeda/Shire: Honoraria (Ongoing)
• 

  Hannah Imlay, MD, MS

  Assistant professor
  Division of Infectious Diseases
  University of Utah Health
  Salt Lake City, UT, United States

  Disclosure(s): No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P